GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Enhabit Inc (NYSE:EHAB) » Definitions » Intrinsic Value: Projected FCF

Enhabit (Enhabit) Intrinsic Value: Projected FCF : $0.00 (As of May. 24, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Enhabit Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-05-24), Enhabit's Intrinsic Value: Projected FCF is $0.00. The stock price of Enhabit is $8.87. Therefore, Enhabit's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for Enhabit's Intrinsic Value: Projected FCF or its related term are showing as below:

EHAB's Price-to-Projected-FCF is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.285
* Ranked among companies with meaningful Price-to-Projected-FCF only.

Enhabit Intrinsic Value: Projected FCF Historical Data

The historical data trend for Enhabit's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enhabit Intrinsic Value: Projected FCF Chart

Enhabit Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Intrinsic Value: Projected FCF
- - - - -

Enhabit Quarterly Data
Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Enhabit's Intrinsic Value: Projected FCF

For the Medical Care Facilities subindustry, Enhabit's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enhabit's Price-to-Projected-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Enhabit's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Enhabit's Price-to-Projected-FCF falls into.



Enhabit Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)



Enhabit  (NYSE:EHAB) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Enhabit's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=8.87/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Enhabit Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Enhabit's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Enhabit (Enhabit) Business Description

Traded in Other Exchanges
Address
6688 N. Central Expressway, Suite 1300, Dallas, TX, USA, 75206
Enhabit Inc provides home health and hospice services in the United States. It offers care where patients prefer it: in their homes. It operates business in two segments: home health and hospice. Its home health agencies provide a comprehensive range of Medicare-certified skilled home health services, including skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services.
Executives
Jeffrey Bolton director 1016 CIVIC CENTER DRIVE NW, ROCHESTER MN 55901
Shaw L Edward Jr director AETNA INC, 151 FARMINGTON AVE RC4B, HARTFORD CT 06156
Stuart M Mcguigan director 74 AGAMENTICUS AVENUE, CAPE NEDDICK ME 03902
Barry P. Schochet director 100 EAST RIVERCENTER BLVD, 16TH FLOOR, COVINGTON KY 41011
Dylan C Black officer: General Counsel and Secretary 6688 CENTRAL EXPRESSWAY, SUITE 1300, DALLAS TX 75206
Langham Ronald Leroy Jr officer: EVP Clinical Excel. & Strategy 6688 CENTRAL EXPRESSWAY, SUITE 1300, DALLAS TX 75206
Higdon Leo I Jr director 1700 LINCOLN STREET, 28TH FLOOR, DENVER CO 80203
Gregory S Rush director TEKELEC, 26580 W. AGOURA RD., CALABASAS CA 91302
Tina L. Brown-stevenson director 6688 N. CENTRAL EXPRESSWAY, SUITE 1300, DALLAS TX 75206
Erin Hoeflinger director 511 FALLVIEW COURT, SPRINGBORO OH 45066
Tanya Renee Marion officer: Chief Human Resources Officer 6688 NORTH CENTRAL EXPRESSWAY, SUITE 1300, DALLAS TX 75206
Charles M Elson director 1401 61STG STREET S, STETSON UNIV COLLEGE OF LAW, ST PETERSBURG FL 33707
Barbara Ann Jacobsmeyer director, officer: President and CEO 2122 ACTON PARK WAY, BIRMINGHAM AL 35243
Yvonne M Curl director C/O ENHABIT, INC., 6688 N. CENTRAL EXPRESSWAY, SUITE 1300, DALLAS TX 75206
Maupin John E Jr D D S director 103 POWELL COURT SUITE 200, BRENTWOOD TN 37027